Exposure to oxygen at a high Fio, can result in substantial damage to several organ systems. In contrast, low-flow oxygen is generally quite safe. Although there have been reports of lung tissue injury with low-flow oxygen, the benefits of this therapy in appropriately selected individuals clearly outweighs the small risks. Elevations in Paco, occur in some COPD patients receiving low-flow oxygen and appear to be related to changes in ventilation-perfusion matching in the lung and carbon dioxide transport in the blood stream rather than to reductions in respiratory drive as previously thought. The effect is generally small in magnitude and is not progressive in response to oxygen therapy alone. Nonmedical hazards such as frostbite and fire related to oxygen equipment have been described but are unusual. Minor problems such as skin rash or nasal irritation in those using low-flow oxygen are usually easily handled with topical treatments. Social and psychological problems resulting from a perceived stigma of wearing oxygen may lead to social isolation of the patient and should be addressed with appropriate counseling and education.
PriestleyJ.Experiments and observations on different kinds of air. Vol II, Sections III-V. In: The discovery of oxygen, Part I. Alembic Club Reprint No. 7. London: Simpkin, Marshall, Hamilton, Kent; 1894: 29–103.
2.
BalentineJ.Pathology of oxygen toxicity. New York: Academic Press; 1982.
3.
SmithJ.The pathological effects due to increase of oxygen tension in the air breathed. J Physiol (London)1899;24:19–35.
4.
ClarkJM, LambertsenCJ. Pulmonary oxygen toxicity: a review. Pharmacol Rev1971;23(2):37–133.
5.
HaugaardN.Cellular mechanisms of oxygen toxicity. Physiol Rev1968;48(2):311–373.
6.
CarrawayMS, PiantadosiCA. Oxygen toxicity. Respir Care Clin N Am1999;5(2):265–295.
7.
LodatoRF. Oxygen toxicity. Crit Care Clin1990;6(3):749–765.
8.
ComroeJ, DrippsR, DumkeP, et al. Oxygen toxicity: the effect of inhalation of high concentration of oxygen for 24 hours on normal men at sea level and at a simulated altitude of 18,000. JAMA1945;128:710–717.
9.
SacknerMA, HirschJA, EpsteinS, RywlinAM. Effect of oxygen in graded concentrations upon tracheal mucous velocity: a study in anesthetized dogs. Chest1976;69(2):164–167.
10.
WagnerPD, LaravusoRB, UhlRR, WestJB. Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2. J Clin Invest1974;54(1):54–68.
11.
CrapoJD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol1986;48:721–731.
12.
FracicaPJ, KnappMJ, CrapoJD. Patterns of progression and markers of lung injury in rodents and subhuman primates exposed to hyperoxia. Exp Lung Res1988;14Suppl:869–885.
13.
BowdenDH, AdamsonYR. Reparative changes following pulmonary cell injury: ultrastructural, cytodynamic, and surfactant studies in mice after oxygen exposure. Arch Pathol1971;92(4):279–283.
14.
CrapoJD, BarryBE, FoscueHA, ShelburneJ.Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis1980;122(1):123–143.
15.
DavisWB, RennardSI, BittermanPB, CrystalRG. Pulmonary oxygen toxicity: early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med1983;309(15):878–883.
16.
BarberRE, HamiltonWK. Oxygen toxicity in man: a prospective study in patients with irreversible brain damage. N Engl J Med1970;283(27):1478–1484.
17.
HydeRW, RawsonAJ. Unintentional iatrogenic oxygen pneumonitis: response to therapy. Ann Intern Med1969;71(3):517–531.
18.
KaplanHP, RobinsonFR, KapanciY, WeibelER. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. 1. Clinical and light microscopic studies. Lab Invest1969;20(1):94–100.
19.
ThomasAN, HallAD. Mechanism of pulmonary injury after oxygen therapy. Am J Surg1970;120(2):255–263.
20.
ChurgA, GoldenJ, FligielS, HoggJC. Bronchopulmonary dyplasia in the adult. Am Rev Respir Dis1983;127(1):117–120.
21.
PiersonDJ. The toxicity of low-flow oxygen therapy. Respir Care1983;28(7):889–897.
22.
PettyTL, StanfordRE, NeffTA. Continuous oxygen therapy in chronic airway obstretion: observations on possible oxygen toxicity and survival. Ann Int Med1971;75(3):361–367.
23.
StewartBN, HoodCI, BlockAJ. Long-term results of continuous oxygen therapy at sea level. Chest1975;68(4):486–492.
24.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med1980;93(3):391–398.
25.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet1981;1(8222):681–686.
FreemanBA, TopoloskyMK, CrapoJD. Hyperoxia increases oxygen radical production in rat lung homogenates. Arch Biochem Biophys1982;216(2):477–484.
28.
FreemanBA, CrapoJD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem1981;256(21):10986–10992.
29.
FreemanBA, CrapoJD. Biology of disease: free radicals and tissue injury. Lab Invest1982;47(5):412–426.
30.
SaltzmanHA, FridovichI.Oxygen toxicity. Introduction to a protective enzyme: superoxide dismutase (editorial). Circulation1973;48(5):921–923.
31.
GraveGD, KennedyC, SokoloffL.Impairment of growth and development of the rat brain by hyperoxia at atmospheric pressure. J Neurochem1972;19(1):187–194.
32.
ClarkJ.Current concepts in oxygen toxicity. In: BacrachA, MatzenM, editors. Underwater Physiology VII. Prodeedings of the Seventh Symposium on Underwater Physiology. Bethesda, MD: Undersea Medical Society; 1981:3–21.
33.
CrapoJD, TierneyDF. Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol1974;226(6):1401–1407.
34.
DonaldK.Neurological effects of oxygen. Lancet1949;ii:1056–1057.
HansonCW3rd, MarshallBE, FraschHF, MarshallC.Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit Care Med1996;24(1):23–28.
37.
AubierM, MurcianoD, Milic-EmiliJ, TouatyE, DaghfousJ, ParienteR, DerenneJP. Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis1980;122(5):747–754.
38.
SassoonCS, HassellKT, MahutteCK. Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease. Am Rev Respir Dis1987;135(4):907–911.
39.
SpearmanC, SheldonR, EganD.Egan's fundamentals of respiratory therapy. St Louis: CV Mosby; 1982.
40.
ClamannH.Fire hazards. Ann NY Acad Sci1965;117:814.
41.
WestGA, PrimeauP.Nonmedical hazards of long-term oxygen therapy. Respir Care1983;28(7):906–912.
42.
BlackmerR.Fire safety of OECO oxygen enricher (pamphlet). Schenectady: Oxygen Enrichment Company, Jun 3, 1982.
43.
StarkRD, BishopJM. New method for oxygen therapy in the home using an oxygen concentrator. Br Med J1973;2(858):105–106.
44.
LamptonL.Home and out-patient oxygen therapy. In: BrashearR, RhodesM, editors. Chronic obstructive lung disease: clinical treatment and management. St. Louis: CV Mosby; 1978.
45.
McLaughlinAJJr. Allergic contact dermatitis from oxygen cannulas. Respir Care1980;25(10):1024–1026.
